Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abiraterone Acetate in ER+ Metastatic Breast Cancer
NCT01381874Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Aug 2011
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 2 trial of Abiraterone Acetate Tablets (I) in breast cancer, sponsored by Janssen Pharmaceutical. Started Aug 2011; status: completed.
02
Drugs
Abiraterone Acetate Tablets (I)
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT01381874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01381874.